Brokerages Anticipate Quaker Chemical Corp (KWR) to Post $1.55 EPS

Share on StockTwits

Brokerages forecast that Quaker Chemical Corp (NYSE:KWR) will report earnings per share of $1.55 for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Quaker Chemical’s earnings, with the lowest EPS estimate coming in at $1.45 and the highest estimate coming in at $1.63. Quaker Chemical reported earnings of $1.56 per share during the same quarter last year, which would suggest a negative year over year growth rate of 0.6%. The business is scheduled to report its next earnings results on Monday, July 29th.

According to Zacks, analysts expect that Quaker Chemical will report full year earnings of $6.80 per share for the current year, with EPS estimates ranging from $6.64 to $6.95. For the next fiscal year, analysts anticipate that the firm will post earnings of $8.37 per share, with EPS estimates ranging from $8.03 to $8.70. Zacks Investment Research’s earnings per share averages are an average based on a survey of research analysts that that provide coverage for Quaker Chemical.

Quaker Chemical (NYSE:KWR) last posted its quarterly earnings results on Thursday, May 2nd. The specialty chemicals company reported $1.41 EPS for the quarter, topping the Zacks’ consensus estimate of $1.40 by $0.01. Quaker Chemical had a return on equity of 18.73% and a net margin of 6.99%. The company had revenue of $211.20 million for the quarter, compared to analysts’ expectations of $213.99 million. During the same period in the previous year, the firm earned $1.41 EPS. The firm’s revenue was down .4% compared to the same quarter last year.

KWR has been the topic of several recent research reports. Janney Montgomery Scott reaffirmed a “neutral” rating and set a $198.00 price objective on shares of Quaker Chemical in a report on Tuesday, January 29th. Seaport Global Securities reaffirmed a “neutral” rating on shares of Quaker Chemical in a report on Tuesday, February 5th. Finally, Zacks Investment Research raised Quaker Chemical from a “sell” rating to a “hold” rating in a report on Thursday, May 2nd. Five research analysts have rated the stock with a hold rating, Quaker Chemical presently has a consensus rating of “Hold” and an average price target of $187.25.

A number of large investors have recently added to or reduced their stakes in KWR. Norges Bank purchased a new stake in Quaker Chemical during the 4th quarter valued at $25,248,000. WINTON GROUP Ltd raised its holdings in Quaker Chemical by 1,252.2% during the 4th quarter. WINTON GROUP Ltd now owns 61,933 shares of the specialty chemicals company’s stock valued at $11,006,000 after buying an additional 57,353 shares during the period. SEI Investments Co purchased a new stake in Quaker Chemical during the 1st quarter valued at $4,190,000. Pennsylvania Trust Co raised its holdings in Quaker Chemical by 248.9% during the 1st quarter. Pennsylvania Trust Co now owns 29,307 shares of the specialty chemicals company’s stock valued at $1,665,000 after buying an additional 20,907 shares during the period. Finally, JPMorgan Chase & Co. raised its holdings in Quaker Chemical by 2.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 720,324 shares of the specialty chemicals company’s stock valued at $145,658,000 after buying an additional 18,869 shares during the period. Institutional investors own 97.83% of the company’s stock.

Shares of KWR traded down $3.87 during mid-day trading on Friday, hitting $197.45. 68,100 shares of the stock were exchanged, compared to its average volume of 75,740. The stock has a market capitalization of $2.66 billion, a price-to-earnings ratio of 32.69, a price-to-earnings-growth ratio of 2.67 and a beta of 1.41. Quaker Chemical has a 52-week low of $151.43 and a 52-week high of $224.30. The company has a debt-to-equity ratio of 0.07, a current ratio of 2.65 and a quick ratio of 2.02.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 31st. Stockholders of record on Wednesday, July 17th will be issued a dividend of $0.385 per share. This represents a $1.54 annualized dividend and a dividend yield of 0.78%. This is a boost from Quaker Chemical’s previous quarterly dividend of $0.37. The ex-dividend date is Tuesday, July 16th. Quaker Chemical’s dividend payout ratio is 24.50%.

About Quaker Chemical

Quaker Chemical Corporation develops, produces, and markets various formulated chemical specialty products for a range of heavy industrial and manufacturing applications in North America, Europe, the Middle East, Africa, the Asia/Pacific, and South America. The company's products include rolling lubricants used by manufacturers of steel in the hot and cold rolling of steel, and aluminum in the hot rolling of aluminum; machining and grinding compounds for use in cutting, shaping, and grinding metal parts; hydraulic fluids for steel, metalworking, and other customers to operate hydraulic equipment; corrosion preventives to protect metals during manufacture, storage, and shipment; and specialty greases used in automotive and aerospace production processes, steel manufacturing, and various other applications.

Recommended Story: How to find the components of the quick ratio

Get a free copy of the Zacks research report on Quaker Chemical (KWR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Quaker Chemical (NYSE:KWR)

Receive News & Ratings for Quaker Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quaker Chemical and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

BlackRock Income Trust  Position Lowered by Bank of America Corp DE
BlackRock Income Trust Position Lowered by Bank of America Corp DE
Ballew Advisors Inc Lowers Holdings in iShares Edge MSCI Min Vol USA ETF
Ballew Advisors Inc Lowers Holdings in iShares Edge MSCI Min Vol USA ETF
Bank of America Corp DE Has $527,000 Holdings in La Jolla Pharmaceutical
Bank of America Corp DE Has $527,000 Holdings in La Jolla Pharmaceutical
Ventas  Upgraded by ValuEngine to Buy
Ventas Upgraded by ValuEngine to Buy
Aspiriant LLC Has $600,000 Stake in iShares Core S&P Mid-Cap ETF
Aspiriant LLC Has $600,000 Stake in iShares Core S&P Mid-Cap ETF
IHS Markit  Raised to Strong-Buy at BidaskClub
IHS Markit Raised to Strong-Buy at BidaskClub


© 2006-2019 Ticker Report